Status:
UNKNOWN
Assessment in Patients After Thoracic Surgery
Lead Sponsor:
Universidad de Granada
Conditions:
Thoracic Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Lung cancer is the leading cause of death in men and the second in women with a 5 year survival in Europe of less than 15%. One of the methods most used for its treatment is pulmonary resection. The o...
Detailed Description
One of the most widely used methods for the treatment of lung cancer is pulmonary resection. The morbidity and mortality of pulmonary resection surgery is conditioned by both the type of intervention ...
Eligibility Criteria
Inclusion
- Patient admitted for lung resection and who sign the informed consent
Exclusion
- Patients who did not agree to sign informed consent and those who presented other types of problems to be able to adequately carry out the assessment, such as not handling the language.
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03300622
Start Date
September 1 2017
End Date
July 1 2018
Last Update
October 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Physical Therapy
Granada, Spain, 18071